Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Pool Corp
POOL
HK Stock MarketDetailed Quotes
01069 CN HEALTH TECH
- 0.044
- -0.005-10.20%
Market Closed May 2 16:08 CST
37.81MMarket Cap11.00P/E (TTM)
0.046High0.043Low4.66MVolume0.045Open0.049Pre Close205.09KTurnover0.54%Turnover Ratio0.17P/E (Static)859.24MShares0.11552wk High1.42P/B37.81MFloat Cap0.03252wk Low--Dividend TTM859.24MShs Float34.640Historical High--Dividend LFY6.12%Amplitude0.032Historical Low0.044Avg Price16000Lot Size--Div YieldTTM--Div Yield LFY
About CN HEALTH TECH Company
China Baosha Development Holdings Limited mainly engages in (a) forestry management; (b) lending; and (c) services related to the management, leasing, sale and installation of container houses.
Company Profile
Symbol01069
Company NameCN HEALTH TECH
ISINKYG2152K1186
Listing DateMay 16, 2011
FoundedJun 10, 2009
Registered AddressCayman Islands
Chairmanfeng ling
Secretaryyifen chen
Audit InstitutionChina Credit Letter (Hong Kong) Certified Public Accountants Limited
Company CategoryOther
Registered OfficeClifton House 75 Fort Street PO Box 1350 Grand Cayman KY1-1108 Cayman Islands
Head Office and Principal Place of BusinessRoom 12, 12th floor, Block A, New Mandarin Centre, 14 Science Museum Road, Tsim Sha Tsui, Kowloon, Hong Kong
Fiscal Year Ends06-30
Employees27
MarketHong Kong motherboard
Phone(852)35906506
Fax(852)30139663
Emailinfo@01069.com.cn
Websitehttp://www.01069.com.cn
Business China Health Technology Group Holdings Co., Ltd. (former name: China Baosha Development Holdings Co., Ltd.) is a company mainly engaged in forestry management and ginseng business. The company's forestry business is mainly engaged in the sale of forest harvested logs. The company's ginseng business is mainly engaged in growing and selling hybrid varieties of ginseng from traditional wild people from northern or cold regions participating in different varieties of ginseng. The company mainly operates in the domestic market.
Company Executives
- Name
- Position
- Salary
- feng ling
- Chairman of the Board, Executive Director, Authorized Representative
- 258.00K
- yibin wang
- CEO, Executive Director, Nomination Committee Members
- 222.00K
- xue bi
- Executive Director
- 79.00K
- zhonglong guo
- Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members, Remuneration Committee Members
- 221.00K
- yingnan zhou
- Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Chairman
- 79.00K
- shuhua liu
- Independent Non-Executive Director, Remuneration Committee Members, Audit Committee Members, Nomination Committee Members
- --
- yifen chen
- Authorized Representative, Company Secretary
- --
- zhiliang li
- CEO of Nemo Biotechnology Co., Ltd.
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting